JIA Xianglong,ZHANG Bo,JIAO Linxi,et al.Experience of XU Xuying in syndrome differentiation and treatment of erysipelas of lower limbs by stages[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(07):802-804.
JIA Xianglong,ZHANG Bo,JIAO Linxi,et al.Experience of XU Xuying in syndrome differentiation and treatment of erysipelas of lower limbs by stages[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(07):802-804. DOI: 10.16025/j.1674-1307.2024.07.018.
LI A, WANG N, GE L, et al. Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study[J]. BMC Infect Dis, 2021,21(1):26.
BEDNARSKA A, SOSIńSKA-BRYłA I, GRĄBCZEWSKI P, et al. The effectiveness of erysipelas prophylaxis depends on the cumulative dose of benzathine penicillin G[J]. Dermatol Reports, 2022,14(3):9429.
SAPUłA M, KRANKOWSKA D, WIERCIńSKA-DRAPAłO A. In search of risk factors for recurrent erysipelas and cellulitis of the lower limb: A cross-sectional study of epidemiological characteristics of patients hospitalized due to skin and soft-tissue infections[J]. Interdiscip Perspect Infect Dis, 2020:1307232.
BRISHKOSKA-BOSHKOVSKI V, KONDOVA-TOPUZOVSKA I, DAMEVSKA K, et al. Comorbidities as risk factors for acute and recurrent erysipelas[J]. Open Access Maced J Med Sci, 2019,7(6):937-942.
KARLSSON T, HOFFNER M, BRORSON H. Liposuction and controlled compression therapy reduce the erysipelas incidence in primary and secondary lymphedema[J]. Plast Reconstr Surg Glob Open, 2022,10(5):e4314.